BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 22, 2011
View Archived Issues
Macro Woes Could Impact Biotech Financing, M&A
The economic situation over the last month or so "reminds a lot of people of 2008 and I can understand why," said Andy Busch, global currency and public policy strategist for BMO Capital Markets, during a recent conference call.
Read More
New Use for Cash? Amgen Gives NPS Royalty Advance
Read More
Up-Front Milestone Balance Shifting in Biotechs' Favor
Read More
Money Raised Year to Date
Read More
Money Raised By Biotech in 2011
Read More
Week in Review
Read More
Word on the Street
Read More
Week in Washington
Read More
Collaborations Between Biotechnology Companies And Government/Nonprofit Institutions: March 1 - August 19, 2011
Read More
Stock Gainers and Losers For The Week
Read More
BioWorld Stock Report For Public Biotechnology Companies
Read More